Evidence map›Paper›PMID 23797033›Full record

ReviewFree radical biology & medicine2013

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Emanuele D'Amico, Pam Factor-Litvak, Regina M Santella, Hiroshi Mitsumoto

Open access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 6 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 6 syntheses or guidelines pooled it, 311 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Efficacy and safety of edaravone in treatment of amyotrophic lateral sclerosis-a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Pooled it
  5. Pooled it
  6. The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis.Journal of molecular neuroscience : MN · 2018
    Pooled it
  7. Trial
  8. Serum urate at trial entry and ALS progression in EMPOWER.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2017
    Trial
  9. Article
  10. Review
  11. LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exploratory associations between APOE-εFrontiers in neurology · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Review

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emanuele D'AmicoEleanor and Lou Gehrig MDA/ALS Research Center, The Neurological Institute of New York, Columbia University Medical Center, New York, NY 10032, USA.
Pam Factor-LitvakDepartment of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY 10032, USA.
Regina M SantellaDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY 10032, USA.
Hiroshi MitsumotoEleanor and Lou Gehrig MDA/ALS Research Center, The Neurological Institute of New York, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: hm264@columbia.edu.
Columbia University Irving Medical Center · US

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
BIOLOGICAL MONITORING FOR EXPOSURE TO AFLATOXINR01ES005116 · NIEHS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SANTELLA, REGINA M · 1990 to 2014
$5.2M
Multicenter ALS Cohort Study of Oxidative Stress and Disease ProgressionR01ES016348 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MITSUMOTO, HIROSHI · 2009 to 2013
$3.5M
Prenatal Organochlorine Metabolites, Thyroid Function and DevelopmentR01ES017024 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FACTOR-LITVAK, PAM R · 2009 to 2010
$1.0M
MicroRNA in Blood as an Early Biomarker of Breast CancerR03CA159427 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SANTELLA, REGINA M · 2011 to 2012
$160k
NCI NIH HHS R03 CA159427NCI NIH HHS R03CA159427NIEHS NIH HHS 1R01ES0122315NIEHS NIH HHS 1R01ES016348NIEHS NIH HHS 1R01ES017024NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P30ES009089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS R01 ES005116NIEHS NIH HHS R01ES005116NIEHS NIH HHS R01 ES016348NIEHS NIH HHS R01 ES017024
6 · The paper itself

Abstract

Sporadic amyotrophic lateral sclerosis (ALS) is one of the most devastating neurological diseases; most patients die within 3 to 4 years after symptom onset. Oxidative stress is a disturbance in the pro-oxidative/antioxidative balance favoring the pro-oxidative state. Autopsy and laboratory studies in ALS indicate that oxidative stress plays a major role in motor neuron degeneration and astrocyte dysfunction. Oxidative stress biomarkers in cerebrospinal fluid, plasma, and urine are elevated, suggesting that abnormal oxidative stress is generated outside of the central nervous system. Our review indicates that agricultural chemicals, heavy metals, military service, professional sports, excessive physical exertion, chronic head trauma, and certain foods might be modestly associated with ALS risk, with a stronger association between risk and smoking. At the cellular level, these factors are all involved in generating oxidative stress. Experimental studies indicate that a combination of insults that induce modest oxidative stress can exert additive deleterious effects on motor neurons, suggesting that multiple exposures in real-world environments are important. As the disease progresses, nutritional deficiency, cachexia, psychological stress, and impending respiratory failure may further increase oxidative stress. Moreover, accumulating evidence suggests that ALS is possibly a systemic disease. Laboratory, pathologic, and epidemiologic evidence clearly supports the hypothesis that oxidative stress is central in the pathogenic process, particularly in genetically susceptive individuals. If we are to improve ALS treatment, well-designed biochemical and genetic epidemiological studies, combined with a multidisciplinary research approach, are needed and will provide knowledge crucial to our understanding of ALS etiology, pathophysiology, and prognosis.

Indexed as

Amyotrophic Lateral SclerosisAnimalsHumansNerve DegenerationOxidative Stress3-nitrotyrosine3-NT4-hydroxy-2-nonenal8-oxo-deoxyguanosine8-oxodGALADALSamyotrophic lateral sclerosisANGangiogeninApoEapolipoprotein Ecentral nervous systemcerebrospinal fluidchronic traumatic encephalopathyCNSCSFCTEDisease prognosisendoplasmic reticulumEnvironmental epidemiologyERF2-isoprostanesfALSfamilial ALSforced vital capacityFree radicalsfrontotemporal dementiaFTDFVCglutathioneGSHHDLhigh-density lipoproteinHNEIsoPsLDLlow-density lipoproteinmalondialdehydeMDAmetallothioneinMNDmotor neuron diseaseMTNADPHnicotinamide adenine dinucleotide phosphatenitric oxide synthetaseNOSoxidation resistance 1Oxidative stressOXR1paraoxonase 1Parkinson diseasePDPhenotypic variationPONreactive nitrogen speciesreactive oxygen speciesRNSROSsALSsingle-nucleotide polymorphismSMNSNPSOD1sporadic ALSSporadic ALSsuperoxide dismutase 1survival motor neuronTAR DNA-binding proteinTBARSTDP-43thiobarbituric acid-reactive substancesVAPBvascular endothelial growth factorVCPVCP, valosin-containing proteinVEGFvesicle associated protein-associated protein Bδ-aminolevulinic acid dehydratase

Identifiers

PMID23797033
PMCPMC3859834
OpenAlexW2026406888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.